Superiority of cisplatin or carboplatin in combination with teniposide and vincristine in the induction chemotherapy of small-cell lung cancer. A randomized trial with 5 years follow up

Analysis of Binary Data

2008 • 2,760 citations

A mathematic model for relating the drug sensitivity of tumors to their spontaneous mutation rate.

1979 • 1,331 citations

A Meta-Analysis of Thoracic Radiotherapy for Small-Cell Lung Cancer

1992 • 1,295 citations

Randomized study of cyclophosphamide, doxorubicin, and vincristine versus etoposide and cisplatin versus alternation of these two regimens in extensive small-cell lung cancer: a phase III trial of the Southeastern Cancer Study Group.

1992 • 532 citations

Long-term survival in small-cell lung cancer: posttreatment characteristics in patients surviving 5 to 18+ years--an analysis of 1,714 consecutive patients.

1995 • 267 citations

Superiority of Alternating Non-Cross-Resistant Chemotherapy in Extensive Small Cell Lung Cancer

1987 • 227 citations

Phase II study of paclitaxel in patients with extensive-disease small-cell lung cancer: an Eastern Cooperative Oncology Group study.

1995 • 178 citations

Longevity in small cell lung cancer

1990 • 158 citations

Carboplatin: a very active new cisplatin analog in the treatment of small cell lung cancer.

1985 • 151 citations

Canadian multicenter randomized trial comparing sequential and alternating administration of two non-cross-resistant chemotherapy combinations in patients with limited small-cell carcinoma of the lung.

1987 • 146 citations

Gemcitabine is an active new agent in previously untreated extensive small cell lung cancer (SCLC)

1994 • 144 citations

Controlled trial of twelve versus six courses of chemotherapy in the treatment of small-cell lung cancer

1989 • 104 citations

Carboplatin (Paraplatin; JM8) and etoposide (VP-16) as first-line combination therapy for small-cell lung cancer.

1987 • 96 citations

Controlled trial of twelve versus six courses of chemotherapy in the treatment of small-cell lung cancer. Report to the Medical Research Council by its Lung Cancer Working Party

1989 • 89 citations

Chemotherapy versus chemotherapy plus irradiation in limited small cell lung cancer. Results of a controlled trial with 5 years follow-up

1986 • 86 citations

Management of small-cell cancer of the lung

1992 • 84 citations

Review of therapeutic trials of carboplatin in lung cancer.

1989 • 75 citations

Teniposide (VM-26), an overlooked highly active agent in small-cell lung cancer. Results of a phase II trial in untreated patients.

1986 • 73 citations

Continuous versus alternating combination chemotherapy for advanced small cell carcinoma of the lung.

1983 • 66 citations

Chemotherapy of small-cell carcinoma of lung: a randomized comparison of alternating and sequential combination chemotherapy programs.

1984 • 50 citations

Etoposide (VP-16) in the treatment of lung cancer

1983 • 50 citations

Teniposide and etoposide in previously untreated small-cell lung cancer: a randomized study.

1991 • 48 citations

Chemotherapy in small cell lung cancer: a consensus report

1989 • 47 citations

Cyclic alternating 'non-cross resistant' chemotherapy in the management of small cell anaplastic carcinoma of the lung

1984 • 37 citations

Phase II study of teniposide in small cell carcinoma of the lung.

1984 • 25 citations

Alternating or sequential chemotherapy in small cell lung cancer?

1989 • 20 citations

Phase II and III studies with carboplatin in small cell lung cancer.

1992 • 16 citations

Management of small-cell lung cancer

1994 • 9 citations